Context Therapeutics Inc
NASDAQ:CNTX
Balance Sheet
Balance Sheet Decomposition
Context Therapeutics Inc
Context Therapeutics Inc
Balance Sheet
Context Therapeutics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
50
|
36
|
14
|
94
|
|
| Cash Equivalents |
0
|
0
|
50
|
36
|
14
|
94
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
2
|
3
|
|
| Total Current Assets |
0
|
0
|
51
|
38
|
16
|
98
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+74%
|
51
+10 817%
|
38
-26%
|
16
-58%
|
98
+511%
|
|
| Liabilities | |||||||
| Accounts Payable |
2
|
3
|
2
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
1
|
1
|
2
|
2
|
1
|
|
| Short-Term Debt |
22
|
6
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
24
|
10
|
3
|
3
|
4
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
24
N/A
|
10
-60%
|
3
-69%
|
3
+6%
|
4
+31%
|
3
-32%
|
|
| Equity | |||||||
| Common Stock |
0
|
8
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
19
|
29
|
44
|
68
|
95
|
|
| Additional Paid In Capital |
1
|
2
|
78
|
79
|
80
|
190
|
|
| Total Equity |
24
N/A
|
9
+62%
|
48
N/A
|
35
-28%
|
12
-66%
|
95
+703%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+74%
|
51
+10 817%
|
38
-26%
|
16
-58%
|
98
+511%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
7
|
11
|
16
|
16
|
16
|
90
|
|